Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipientsJesse W. Keller, Rebecca L. Olin, Lloyd E. Damon et al.|Journal of Geriatric Oncology|2014Cited by 28
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisGabriel N. Mannis, Thomas G. Martin, Aaron C. Logan et al.|Bone Marrow Transplantation|2014Cited by 13
Comprehensive Geriatric Assessment Identifies Significant Functional Impairments in Older Hematopoietic Cell Transplant RecipientsRebecca L. Olin, Lloyd E. Damon, Charalambos Andreadis et al.|Transplantation and Cellular Therapy|2014Cited by 10
<p>Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the <em>ALK</em> Gene Have Durable Responses to ALK Kinase Inhibitors</p>Alexa B. Schrock, Siraj M. Ali, Russell W. Madison et al.|Lung Cancer Targets and Therapy|2020Cited by 3
A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acute Myeloid LeukemiaGabriel N. Mannis, Thomas G. Martin, Charalambos Andreadis et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 3